Eric Venker
Director, Chief Executive Officer; President & Immunovant CEO · 10 filings · Latest: Jul 27, 2026
Immunovant, Inc.
Roivant Sciences Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ROIV | Venker Eric | — | Jul 21, 2025 | Proposed Sale | $11.52 | 100,000 | $1.2M | — | |
ROIV | Venker Eric | — | Jun 20, 2025 | Proposed Sale | $11.45 | 100,000 | $1.1M | — | |
ROIV | ERIC VENKER | — | Jun 3, 2025 | Proposed Sale | $11.22 | 566,278 | $6.4M | — | |
ROIV | ERIC VENKER | — | Jun 2, 2025 | Proposed Sale | $11.07 | 433,722 | $4.8M | — | |
ROIV | Venker Eric | — | May 20, 2025 | Proposed Sale | $10.95 | 100,000 | $1.1M | — | |
ROIV | Venker Eric | — | Apr 21, 2025 | Proposed Sale | $10.22 | 100,000 | $1.0M | — | |
ROIV | Venker Eric | — | Mar 20, 2025 | Proposed Sale | $10.95 | 650,000 | $7.1M | — | |
ROIV | Venker Eric | — | Mar 20, 2025 | Proposed Sale | $11.11 | 100,000 | $1.1M | — | |
ROIV | Venker Eric | — | Feb 20, 2025 | Proposed Sale | $10.65 | 100,000 | $1.1M | — | |
ROIV | Venker Eric | — | Feb 12, 2025 | Proposed Sale | $10.50 | 600,000 | $6.3M | — | |
ROIV | Venker Eric | — | Jan 21, 2025 | Proposed Sale | $11.28 | 100,000 | $1.1M | — | |
ROIV | Venker Eric | — | Dec 27, 2024 | Proposed Sale | $11.75 | 360,000 | $4.2M | — | |
ROIV | Venker Eric | — | Nov 20, 2024 | Proposed Sale | $11.49 | 100,000 | $1.1M | — | |
ROIV | Venker Eric | — | Nov 20, 2024 | Proposed Sale | $11.32 | 100,000 | $1.1M | — | |
ROIV | Venker Eric | — | Oct 21, 2024 | Proposed Sale | $11.65 | 100,000 | $1.2M | — |
← Previous
Page 3 of 3